Hidradenitis Suppurativa 2018-2028 in 21 Major Markets – ResearchAndMarkets.com

The “Epiomic
Epidemiology Series: Hidradenitis Suppurativa Forecast In 21 Major
Markets 2018-2028” report has been added to ResearchAndMarkets.com’s
offering.

This report provides the current prevalent population for HS across 21
Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland,
Netherlands, Belgium, Denmark, Russia, Turkey, Japan, China, South
Korea, Singapore, Australia, Brazil, Mexico, Argentina) split by gender
and 5-year age cohort. In addition to the current prevalence, the report
provides an overview of the risk factors, diagnosis and prognosis of the
disease, along with specific variations by geography and ethnicity.

Providing a value-added level of insight from our analysis team, HS
patients grouped by disease stages, grades, phenotypes, number and type
of lesions, certain parameters, as well as signs and comorbidities have
been quantified and presented alongside the overall prevalence figures.
These sub-populations within the main disease are also included at a
country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities of HS include:

Reasons to buy

Key Topics Covered:

For more information about this report visit https://www.researchandmarkets.com/research/xdq277/hidradenitis?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20180712005656/en/

Leave a Comment